Thioray 15 Mg Injection

Thiotepa 15 Mg

Thiotepa 15mg Injection belongs to the class of medication known as Antineoplastics. It contains the active ingredient Thiotepa. It is prescribed in combination with other anti-cancer drugs before stem cell transplantation for adult patients with cancer in the lymph nodes of the central nervous system. It is used as a Preparation before stem cell transplant to reduce the risk of graft rejection. It controls the outflow within the cavity due to cancer in serous membranes. It is also indicated for treating breast, ovarian, and bladder cancer. The common side effects that are likely to be associated with Thiopta 15mg Injection are diarrhoea, rashes, bleeding, blood in urine, and cytomegalovirus infection. Inform your doctor if these side effects disturb or persist in you. It is contraindicated in patients using a live virus or bacterial vaccine, including the yellow fever vaccine. If you have a history of cardiac, liver, kidney, and pulmonary disease and profound myelosuppression (anemia, neutropenia, and thrombocytopenia), report to your doctor. Liver and cardiac function must be monitored regularly, and caution is advised in patients with cardiac disease and liver impairment. It is not recommended to use in pregnant and breastfeeding women.

Thiotepa is used in the treatment of brain tumour, breast cancer, non-small cell lung cancer and ovarian cancer. It is used in combination with other cancer medicine during hematopoietic progenitor cell transplantation (HPCT).